The company was taken over by German BASF in 1975, which sold it to Abbott Laboratories on 30 June 2002 for $6.9 billion.
[1][2] It was the developer of several drugs: Dilaudid (hydromorphone), a powerful and very water-soluble narcotic analgesic (Betäubungsmittel) introduced in 1926, as small oral tablets of a number of strengths, multipurpose (hypodermic) tablets, compounding powder, ampoules of solution for injection, and dry ampoules for reconstitution.
[3] The obverse sides of the oral tablets bear a stylised letter "K" and the reverse has the relevant imprint code for the medication in the locale of sale and/or number of milligrammes of hydromorphone.
[citation needed] Isophan, a slightly modified version of the methamphetamine drug Pervitin, which the nazi government in 1940 distributed to the German army and air force in an effort to win WW2.
[8] Ancrod failed in a Phase III clinical trial in 2008, which led to the demise of NTI.